2 Results for "

unresectable hepatocellular carcinoma

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "unresectable hepatocellular carcinoma" in MCE Product Catalog:

Cat. No.: HY-P9986
CAS No.: 1918185-84-8
Synonyms: MTIG-7192A; RG-6058

Target:  

CD28

Research Areas:  

Cancer

Tiragolumab is an immune checkpoint inhibitor binding to the T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab in combination with Atezolizumab (HY-P9904) and Bevacizumab (HY-P9906) has benefit in unresectable hepatocellular carcinoma. Tiragolumab can be used to study non-small cell lung cancer (NSCLC) and melanoma .
loading...
    loading...
Cat. No.: HY-P99758
CAS No.: 2377845-98-0
Synonyms: CS1003

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab shows antitumor activity and can be used for the research of unresectable or metastatic hepatocellular carcinoma .
loading...
    loading...